Format

Send to

Choose Destination
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11904-E11913. doi: 10.1073/pnas.1810413115. Epub 2018 Nov 19.

ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.

Author information

1
Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536.
2
Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536.
3
Department of Neurology, College of Medicine, University of Kentucky, Lexington, KY 40536.
4
Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536; haining@uky.edu.
5
Lexington VA Medical Center, Research and Development, Lexington, KY 40502.

Abstract

Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease characterized by preferential motor neuron death. Approximately 15% of ALS cases are familial, and mutations in the fused in sarcoma (FUS) gene contribute to a subset of familial ALS cases. FUS is a multifunctional protein participating in many RNA metabolism pathways. ALS-linked mutations cause a liquid-liquid phase separation of FUS protein in vitro, inducing the formation of cytoplasmic granules and inclusions. However, it remains elusive what other proteins are sequestered into the inclusions and how such a process leads to neuronal dysfunction and degeneration. In this study, we developed a protocol to isolate the dynamic mutant FUS-positive cytoplasmic granules. Proteomic identification of the protein composition and subsequent pathway analysis led us to hypothesize that mutant FUS can interfere with protein translation. We demonstrated that the ALS mutations in FUS indeed suppressed protein translation in N2a cells expressing mutant FUS and fibroblast cells derived from FUS ALS cases. In addition, the nonsense-mediated decay (NMD) pathway, which is closely related to protein translation, was altered by mutant FUS. Specifically, NMD-promoting factors UPF1 and UPF3b increased, whereas a negative NMD regulator, UPF3a, decreased, leading to the disruption of NMD autoregulation and the hyperactivation of NMD. Alterations in NMD factors and elevated activity were also observed in the fibroblast cells of FUS ALS cases. We conclude that mutant FUS suppresses protein biosynthesis and disrupts NMD regulation, both of which likely contribute to motor neuron death.

KEYWORDS:

RNA-protein granules; amyotrophic lateral sclerosis; fused in sarcoma; nonsense-mediated decay; protein translation

Comment in

PMID:
30455313
PMCID:
PMC6304956
DOI:
10.1073/pnas.1810413115
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center